Trials / Terminated
TerminatedNCT01612793
Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations
Non-Invasive Vagus Nerve Stimulation With the AlphaCore Device for Management of Bronchoconstriction in Patients Hospitalized With COPD
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 4 (actual)
- Sponsor
- ElectroCore INC · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
This study will look at the safety, improving symptoms and decreasing the length of stay of patients admitted to the hospital with COPD.
Detailed description
The primary safety measurement for this study is the type, occurrence and severity of adverse events (anticipated and unanticipated), including serious and non-serious device-related events. The primary outcome measure is hospital length of stay (LOS) defined as the number of days from hospital admission to the date the subject meets the medical elements of the GOLD Discharge Criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AlphaCore Device | multiple stimulation treatments per day for duration of hospitalization |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2012-06-06
- Last updated
- 2019-02-28
- Results posted
- 2019-02-28
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01612793. Inclusion in this directory is not an endorsement.